DIPLOMAT PHARMACY INC's ticker is and the CUSIP is 25456K901. A total of 3 filers reported holding DIPLOMAT PHARMACY INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $826,000 | +5062.5% | 2,066 | +6160.6% | 0.00% | – |
| Q3 2019 | $16,000 | -74.6% | 33 | -68.6% | 0.00% | – |
| Q2 2019 | $63,000 | -91.0% | 105 | -91.3% | 0.00% | -100.0% |
| Q1 2019 | $698,000 | +1007.9% | 1,203 | +2459.6% | 0.00% | – |
| Q4 2018 | $63,000 | +600.0% | 47 | +840.0% | 0.00% | – |
| Q3 2018 | $9,000 | -47.1% | 5 | -28.6% | 0.00% | – |
| Q2 2018 | $17,000 | – | 7 | +133.3% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 3 | -88.5% | 0.00% | – |
| Q4 2017 | $4,000 | -90.2% | 26 | -86.7% | 0.00% | -100.0% |
| Q3 2017 | $41,000 | +4000.0% | 195 | +209.5% | 0.00% | – |
| Q2 2017 | $1,000 | -80.0% | 63 | -43.8% | 0.00% | – |
| Q1 2017 | $5,000 | +400.0% | 112 | +286.2% | 0.00% | – |
| Q4 2016 | $1,000 | – | 29 | +31.8% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 22 | -73.8% | 0.00% | -100.0% |
| Q2 2016 | $42,000 | +320.0% | 84 | -3.4% | 0.00% | +200.0% |
| Q1 2016 | $10,000 | -50.0% | 87 | -21.6% | 0.00% | -50.0% |
| Q4 2015 | $20,000 | – | 111 | +101.8% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 55 | -45.5% | 0.00% | -100.0% |
| Q2 2015 | $26,000 | +160.0% | 101 | +461.1% | 0.00% | +100.0% |
| Q1 2015 | $10,000 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 29,000 | $833,000 | 0.01% |
| Citadel Advisors | 14,800 | $425,000 | 0.00% |
| SIMPLEX TRADING, LLC | 55 | $0 | 0.00% |